EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the EGFR pathway

Umut Sarı, Fuat Zaman

Acta Cirúrgica Brasileira · 2024

DOI: 10.1590/acb390524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Cirúrgica Brasileira, 2024. Verfasst von Umut Sarı und 1 weiteren Autor:innen. Beteiligte Einrichtung: Umut Sarı Clinic - Department of Gynecology and Obstetrics - Istanbul, Turkey. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsAdenocarcinomaHumansFemaleRosmarinic AcidApoptosisCell Line, TumorDoxorubicinErbB ReceptorsCell Proliferation

Substanzen

Rosmarinic AcidDoxorubicinErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Umut Sarı Clinic - Department of Gynecology and Obstetrics - Istanbul, Turkey.
  • Diyarlife Hospital - Department of Obstetrics and Gynecology - Diyarbakır, Turkey.

Zitieren

APA

Sarı, U., & Zaman, F. (2024). Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the EGFR pathway. Acta Cirúrgica Brasileira. https://doi.org/10.1590/acb390524

Vancouver

Sarı U, Zaman F. Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the EGFR pathway. Acta Cirúrgica Brasileira. 2024. doi:10.1590/acb390524

BibTeX
@article{Sar2024,
  author = {Sarı, Umut and Zaman, Fuat},
  title = {Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the EGFR pathway},
  journal = {Acta Cirúrgica Brasileira},
  year = {2024},
  doi = {10.1590/acb390524}
}
Kostenlos starten →